Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Maggi, IT
Adriana Maggi, Milano IT
| Patent application number | Description | Published |
|---|---|---|
| 20100035796 | 17-ALPHA-SUBSTITUTED DERIVATIVES OF ESTRADIOL WITH WOUND-HEALING ACTIVITY - The invention relates to 17α-(5-hydroxy-C | 02-11-2010 |
| 20110197288 | Transgenic animal for screening of compounds that modulate cell proliferation, and its use in the pharmaceutical field - The present invention relates to a transgenic non-human mammalian animal whose genome incorporates a biosensor of the activity of modulators of cell proliferation consisting of a DNA sequence that comprises the luciferase reporter transgene ligated downstream of a promoter sequence of the CYCB2 gene, this sequence promoter/reporter being flanked by HS4 insulator sequences at each of its 3′ and 5′ sides. | 08-11-2011 |
Adriana Caterina Maggi, Milano IT
| Patent application number | Description | Published |
|---|---|---|
| 20110203008 | TRANSGENIC MOUSE FOR SCREENING AND FOR STUDIES OF THE PHARMACODYNAMICS AND PHARMACOKINETICS OF LIGANDS ACTING ON THE OESTROGEN RECEPTOR AND ITS INTRACELLULAR RECEPTORS, AND METHOD FOR THE PREPARATION THEREOF - The object of the invention is a method for the production of a non-human transgenic mammal by means of which it is possible to monitor in vivo and in all the tissues the state of activation of any intracellular receptor, utilising a reporter gene inducible by natural or synthetic molecules which modulate the activity of such receptor. The mammal is question is preferably a mouse. | 08-18-2011 |
Carlo Alberto Maggi, Firenze IT
| Patent application number | Description | Published |
|---|---|---|
| 20090163695 | Process for the preparation of bicyclic peptide compounds - The present invention relates to a new process carried out entirely in solution, for the preparation in high yields of high purity bicyclic peptide compounds of formula (I), useful as intermediates for preparing compounds with pharmacological activity. | 06-25-2009 |
| 20100234284 | Pharmaceutical compositions based on NK2 antagonists for pediatric use - Pharmaceutical compositions containing NK2 antagonists are described, useful for the treatment of infantile colics. | 09-16-2010 |
| 20100292156 | PHARMACEUTICAL COMPOSITIONS CONTAINING BRADYKININ ANTAGONISTS AND HYALURONIC ACID, AND USES THEREOF - Disclosed are pharmaceutical compositions containing, as the active ingredients, a mixture of a hyaluronic acid polymer with a bradykinin B2 receptor antagonist. Said compositions have proved especially effective in the treatment of degenerative joint diseases such as osteoarthritis using intra-articular injections. | 11-18-2010 |
| 20110112011 | PHARMACEUTICAL COMPOSITIONS BASED ON KININ B2 RECEPTOR ANTAGONISTS AND CORTICOSTEROIDS, AND THEIR USE - Disclosed are pharmaceutical compositions containing, as active ingredients, a mixture of a corticosteroid and a kinin B2 receptor antagonist. Said compositions have proved particularly effective, especially in the treatment of inflammatory disorders such as asthma, ophthalmic or dermatological disorders and, above all, as regards the joints, arthritis. | 05-12-2011 |
Carmelo Maggi, Firenze IT
| Patent application number | Description | Published |
|---|---|---|
| 20130019955 | DIFFERENTIAL PRESSURE VALVE WITH REDUCED SPRING-SURGE AND METHOD FOR REDUCING SPRING SURGE - Disclosed is a differential pressure valve comprising: a valve body, the valve body having at least one flow inlet and one flow outlet: at least one shutter, the shutter being movable between an open position and a closed position under a differential pressure across the valve; at least one flow passage from the flow inlet to the flow outlet; at least one biasing member configured to bias the shutter towards a closed position so as to block the flow passage through the flow inlet. The biasing member is a non-linear biasing member. | 01-24-2013 |
Enrico Maggi, Firenze IT
| Patent application number | Description | Published |
|---|---|---|
| 20080248000 | Stem Cells, Method For Their Purification, Identification, and Use - Herein is described a new population of circulating CD14+cells, with a low density surface expression of CD34 and endowed with stem capacity, a method for their purification and identification, and their therapeutic use. | 10-09-2008 |
| 20090196857 | Kidney-Derived Stem Cell Population, Identification and Therapeutic Use - A novel population of kidney-derived cells is described that exhibits surface co-expression of CD133 and CD24 markers; said cells possess stem cell capacity and are capable of undergoing tubulogenic, adipogenic, osteogenic and neurogenic differentiation. | 08-06-2009 |
Federico Maggi, Colazza IT
| Patent application number | Description | Published |
|---|---|---|
| 20100323441 | METHOD OF COLLECTION AND PRESERVATION OF FLUIDS AND/OR MATERIALS, IN PARTICULAR OF ORGANIC FLUIDS AND/OR MATERIALS CONTAINING STEM CELLS, AND DEVICE EMPLOYABLE IN SUCH METHOD - A method of collection and preservation of a fluid and/or a material comprises a step of determining a sampling volume that is closed and/or separated from the external environment, a step of taking a predetermined amount of fluid and/or material from the sampling volume and a step of confining the fluid and/or material into a collection volume; the step of taking the fluid and/or material and the step of confining the fluid and/or material are simultaneous with each other and contemporaneous with a step of maintaining the hydraulic and/or pneumatic and/or microbiological isolation between the sampling volume and the collection volume. | 12-23-2010 |
Giovanni Maggi, Milano IT
| Patent application number | Description | Published |
|---|---|---|
| 20110206006 | SIGNALING EXCHANGE FOR HANDOVER CONTROL FOR WIRELESS NETWORKS - Various example embodiments are disclosed herein. According to an example embodiment, a technique may include transmitting, from a mobile station to a base station in a wireless network, a message (e.g., a subscriber station basic capability (SBC) request message) indicating whether or not the mobile station supports base station-controlled handover for the mobile station. The technique may also include receiving, by the mobile station from the base station, a message (e.g., a subscriber station basic capability (SBC) response message) indicating whether or not the base station supports base-station controlled handover. | 08-25-2011 |
| 20120276945 | CELL SELECTION TECHNIQUES FOR IDLE MODE FOR WIRELESS NETWORKS - Various example embodiments are disclosed herein. According to an example embodiment, an apparatus may include a processor. The processor may be configured to: make a first determination, by a mobile station in idle mode, that a trigger condition for cell selection has been met for a target base station as compared to a current preferred base station; compare a network specified cell preference of the target base station to a network specified cell preference of the current preferred base station; select the target base station as a new preferred base station if the cell preference of the target base station is the same or lower than the cell preference of the current preferred base station; otherwise, if the cell preference of the target base station is higher than the cell preference of the current preferred base station, then selecting the target base station as a new preferred base station only if the trigger condition for cell selection for the target base station is still met after a delay period after the first determination has been made. | 11-01-2012 |
Giuseppe Maggi, Lecco IT
| Patent application number | Description | Published |
|---|---|---|
| 20080223496 | Snow Chain Attachment System Comprising Elastic Fastening Means - An attachment system for a snow chain is disclosed, comprising a rolling track ( | 09-18-2008 |
Lauretta Maggi, Pavia IT
| Patent application number | Description | Published |
|---|---|---|
| 20100003320 | HYDROPHILIC/LIPOPHILIC POLYMERIC MATRIX DOSAGE FORMULATION - An oral dosage form comprising a pharmaceutical tablet of one or more layers, one of which carries a biologically active substance; the formulation of said tablet includes different percentages of hydrophilic and lipophilic polymeric materials, and adjuvant substances. The tablets of the present invention show a release rate which is independent from the amounts of active substance present in the tablet. | 01-07-2010 |
| 20110177167 | Hydrophilic/Lipophilic Polymeric Matrix Dosage Formulation - An oral dosage form comprising a pharmaceutical tablet of one or more layers, one of which carries a biologically active substance; the formulation of said tablet includes different percentages of hydrophilic and lipophilic polymeric materials, and adjuvant substances. The tablets of the present invention show a release rate which is independent from the amounts of active substance present in the tablet. | 07-21-2011 |
Loretta Maggi, Piacenza IT
| Patent application number | Description | Published |
|---|---|---|
| 20080226736 | Inhalatory Pharmaceutical Compositions in Form of Dry Powders, Solutions or Suspensions Obtained From the Same and Process for their Preparation - Inhalatory pharmaceutical composition comprising a drug, a soluble excipient and a surfactant, characterized by: said soluble excipient is present in an amount between 10% and less than 100% by weight; —the weight ratio between said surfactant and said drug is between 0.01 and 10; —the particle size of at least 50% of the particles of said powder is below 5 μm; —the bulk density d | 09-18-2008 |
Luca Maggi, Garlate IT
| Patent application number | Description | Published |
|---|---|---|
| 20120153771 | MICROELECTROMECHANICAL TRANSDUCER AND CORRESPONDING ASSEMBLY PROCESS - A MEMS transducer has a micromechanical sensing structure and a package. The package is provided with a substrate, carrying first electrical-connection elements, and with a lid, coupled to the substrate to define an internal cavity, in which the micromechanical sensing structure is housed. The lid is formed by: a cap layer having a first surface and a second surface, set opposite to one another, the first surface defining an external face of the package and the second surface facing the substrate inside the package; and a wall structure, set between the cap layer and the substrate, and having a coupling face coupled to the substrate. At least a first electrical component is coupled to the second surface of the cap layer, inside the package, and the coupling face of the wall structure carries second electrical-connection elements, electrically connected to the first electrical component and to the first electrical-connection elements. | 06-21-2012 |
Raimondo Maggi, Parma IT
| Patent application number | Description | Published |
|---|---|---|
| 20100204038 | Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid - Catalysts are described based on metal complexes derived from optically active s compounds, chosen from the classes consisting of bisoxazolines and salicylaldimines supported on an organic or inorganic matrix and employed in particular for the synthesis of optically active chrysanthemic acid. | 08-12-2010 |